ATE269904T1 - Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien - Google Patents
Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterienInfo
- Publication number
- ATE269904T1 ATE269904T1 AT93908349T AT93908349T ATE269904T1 AT E269904 T1 ATE269904 T1 AT E269904T1 AT 93908349 T AT93908349 T AT 93908349T AT 93908349 T AT93908349 T AT 93908349T AT E269904 T1 ATE269904 T1 AT E269904T1
- Authority
- AT
- Austria
- Prior art keywords
- expression
- gramp
- transport
- positive bacteria
- hybrid
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title abstract 3
- 102000018697 Membrane Proteins Human genes 0.000 title abstract 2
- 108010052285 Membrane Proteins Proteins 0.000 title abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Public Health (AREA)
- Crystallography & Structural Chemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85108292A | 1992-03-13 | 1992-03-13 | |
PCT/US1993/002355 WO1993018163A2 (en) | 1992-03-13 | 1993-03-12 | Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE269904T1 true ATE269904T1 (de) | 2004-07-15 |
Family
ID=25309927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93908349T ATE269904T1 (de) | 1992-03-13 | 1993-03-12 | Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0646176B1 (de) |
JP (1) | JP3626181B2 (de) |
AT (1) | ATE269904T1 (de) |
AU (1) | AU674311B2 (de) |
CA (1) | CA2131995A1 (de) |
DE (1) | DE69333560T2 (de) |
DK (1) | DK0646176T3 (de) |
ES (1) | ES2224097T3 (de) |
HU (1) | HU220420B (de) |
WO (1) | WO1993018163A2 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5821088A (en) * | 1990-05-11 | 1998-10-13 | Siga Pharmaceuticals, Inc. | Use of gram-positive bacteria to express recombinant proteins |
WO1993018163A2 (en) * | 1992-03-13 | 1993-09-16 | The Rockefeller University | Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
US5516637A (en) * | 1994-06-10 | 1996-05-14 | Dade International Inc. | Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage |
AUPM885194A0 (en) * | 1994-10-14 | 1994-11-10 | Council Of The Queensland Institute Of Medical Research, The | Synthetic peptides and vaccines comprising same |
GB9518323D0 (en) | 1995-09-07 | 1995-11-08 | Steidler Lothar | Materials and methods relating to the attachment and display of substances on cell surfaces |
US7101692B2 (en) | 1999-04-15 | 2006-09-05 | The Regents Of The University Of California | Identification of sortase gene |
AU784043B2 (en) | 1999-04-15 | 2006-01-19 | Regents Of The University Of California, The | Identification of sortase gene |
JP2002542182A (ja) | 1999-04-16 | 2002-12-10 | オセル・インコーポレーテッド | 粘膜上の可溶性ウイルス特異リガンドの半減期を増加させる方法 |
WO2007082734A2 (en) * | 2006-01-17 | 2007-07-26 | Creatogen Laboratories Gmbh | Influenza vaccine |
IL208820A0 (en) * | 2010-10-19 | 2011-01-31 | Rachel Teitelbaum | Biologic female contraceptives |
US9376686B2 (en) | 2011-09-23 | 2016-06-28 | Forsyth Dental Infirmary For Children | Vaccine and therapeutic delivery system |
US9925257B2 (en) | 2011-09-23 | 2018-03-27 | Forsyth Dental Infirmary For Children | Vaccine and therapeutic delivery system |
MA41020A (fr) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990015872A1 (en) * | 1989-06-21 | 1990-12-27 | The Rockefeller University | Recombinant poxvirus and streptococcal m protein vaccine |
WO1993018163A2 (en) * | 1992-03-13 | 1993-09-16 | The Rockefeller University | Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
SE9101433D0 (sv) * | 1991-05-13 | 1991-05-13 | Marianne Hansson | Recombinant dna sequence and its use |
-
1993
- 1993-03-12 WO PCT/US1993/002355 patent/WO1993018163A2/en active IP Right Grant
- 1993-03-12 AU AU39199/93A patent/AU674311B2/en not_active Ceased
- 1993-03-12 HU HU9402575A patent/HU220420B/hu not_active IP Right Cessation
- 1993-03-12 CA CA002131995A patent/CA2131995A1/en not_active Abandoned
- 1993-03-12 ES ES93908349T patent/ES2224097T3/es not_active Expired - Lifetime
- 1993-03-12 EP EP93908349A patent/EP0646176B1/de not_active Expired - Lifetime
- 1993-03-12 DK DK93908349T patent/DK0646176T3/da active
- 1993-03-12 DE DE69333560T patent/DE69333560T2/de not_active Expired - Fee Related
- 1993-03-12 AT AT93908349T patent/ATE269904T1/de not_active IP Right Cessation
- 1993-03-12 JP JP51605193A patent/JP3626181B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0646176A1 (de) | 1995-04-05 |
WO1993018163A2 (en) | 1993-09-16 |
JP3626181B2 (ja) | 2005-03-02 |
CA2131995A1 (en) | 1993-09-16 |
ES2224097T3 (es) | 2005-03-01 |
WO1993018163A3 (en) | 1993-11-11 |
EP0646176B1 (de) | 2004-06-23 |
HU220420B (hu) | 2002-01-28 |
DK0646176T3 (da) | 2004-11-08 |
DE69333560D1 (de) | 2004-07-29 |
HUT70306A (en) | 1995-09-28 |
AU3919993A (en) | 1993-10-05 |
JP2002509421A (ja) | 2002-03-26 |
AU674311B2 (en) | 1996-12-19 |
DE69333560T2 (de) | 2006-07-13 |
HU9402575D0 (en) | 1994-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE269904T1 (de) | Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien | |
EP0245362A4 (de) | Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc. | |
DK614987D0 (da) | Syntetiske htlv-iii peptider, praeparater og anvendelser deraf | |
FI861626A0 (fi) | Foervaervat immunbristsyndrom (aids) -relaterat viralt rekombinant hoeljeprotein samt ett testfoerfarande foer aids. | |
DK103085D0 (da) | Hepatitis-b-peptidimmunogen | |
ATE150319T1 (de) | Behandlung von asthma | |
DE3881023D1 (de) | Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten. | |
CA2132742A1 (en) | Synthetic Peptides and Vaccines Against Parvovirus | |
DK0383599T3 (da) | Protein-anticancermiddel | |
DE69534242D1 (de) | Hämorrhagie-Virus aus Kaninchen (RHDV), rekombinante Hullen und dessen Proteine, Diagnosesätze und Impfstoffe die sie enthalten | |
SE8900899L (sv) | Peptider foer diagnostisk anvaendning | |
DE69011122T2 (de) | Rubella-e1 und c peptide. | |
RU94040393A (ru) | Синтетические пептиды для вакцины против краснухи | |
BR9303903A (pt) | Fator-4 de plaqueta modificado ou clivado e processo para sua preparaçao, formulaçao farmacêutica, composto e vetor de dna recombinante e célula hospedeira | |
DE3854096D1 (de) | Verfahren zur Isolierung von Basalmembranproteinen aus menschlichen und tierischen Geweben. | |
ATE4637T1 (de) | Pentadecapeptid, verfahren zu seiner herstellung und immunisierendes mittel. | |
ATE119166T1 (de) | An hiv relatierte peptide. | |
DE69513226D1 (de) | Verwendung von Azolen als Virustötende Substanzen in Lösungen von biologisch aktiven Proteinen | |
Sarkar et al. | Species specificity of ribosomal proteins in eucaryotic and procaryotic organisms | |
GB916455A (en) | Non-toxic antigens and process for producing same | |
DK547486A (da) | Peptider samt praeparater indeholdende disse | |
KR950031073A (ko) | 생물학적 활성 단백질의 용액중 바이러스 박멸제로서의 아졸의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0646176 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |